Effects of Korean red ginseng extract on acute renal failure induced by gentamicin and pharmacokinetic changes by metformin in rats

Food and Chemical Toxicology

Volumn 59, Issue , 2013, Pages 153-159

  Lee, Yu Kyung ^a   Chin, Young Won ^a   Choi, Young Hee ^a  

^a Dongguk University   (South Korea)

Author keywords

Acute renal failure; Gentamicin; Korean red ginseng extract; Metformin; Pharmacokinetics; Prevention

Indexed keywords

CREATININE; GENTAMICIN; GINSENG EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RG 1; GINSENOSIDE RG 3; METFORMIN; NITROGEN; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; LIVER MICROSOME; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PLASMA PROTEIN BINDING; QUANTITATIVE ANALYSIS; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ACUTE RENAL FAILURE; GENTAMICIN; KOREAN RED GINSENG EXTRACT; METFORMIN; PHARMACOKINETICS; PREVENTION;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; GENTAMICINS; GINSENOSIDES; HYPOGLYCEMIC AGENTS; INTESTINES; KIDNEY; LIVER; MALE; METFORMIN; MICROSOMES; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

BACTERIA (MICROORGANISMS); PANAX GINSENG; RATTUS;

EID: 84879813738     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.05.025     Document Type: Article

References (40)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
2. Brelsford M., Beute T.C. Preventing and managing the side effects of isotretinoin. Seminars in Cutaneous Medicine and Surgery 2008, 27:197-206.
3. Chiou W.L. Critical evaluation of the potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinetics and Biopharmaceutics 1978, 6:539-546.
4. Choi K.T. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacologica Sinica 2008, 29:1109-1118.
5. Choi Y.H., Lee M.G. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1, and 3A1/2 for the metabolism of metformin. British Journal of Pharmacology 2006, 149:424-430.
6. Choi Y.H., Kim S.G., Lee M.G. Dose-independent pharmacokinetics of metformin after intravenous and oral administration in rats: hepatic and gastrointestinal first-pass effects. Journal of Pharmaceutical Sciences 2006, 95:2543-2552.
7. Choi Y.H., Lee D.C., Lee I., Lee M.G. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin. Journal of Pharmaceutical Sciences 2008, 97:5363-5375.
8. Choung B.S., Shin M.K. The Illustrated Dictionary of Traditional Drugs in Korea 1998, Younglim Press, Seoul, pp. 439-443.
9. Cussocrea S., Mazzon E., Dugo L., Serranino I., Di Paola R., Britti D., De Sarro A. A role for superoxide in gentamicin-mediated nephropathy in rats. European Journal of Pharmacology 2002, 250:67-76.
10. Davis B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 1999, 10:1093-1095.
11. Duggleby R.G. Analysis of enzyme progress curves by nonlinear regression. Methods in Enzymology 1995, 249:61-90.
12. Fuzzati N. Analysis methods of ginsenosides. Journal of Chromatography B 2004, 812:119-133.
13. Gibaldi M., Peorrier D. Pharmacokinetics 1982, Marcel-Dekker, New York, NY. second ed.
14. Ha Y.W., Lim S.S., Ha I.J., Na Y.C., Seo J.J., Shin H., Son S.H., Kim Y.S. Preparative isolation of four ginsenosides from Korean red ginseng (steam-treated Panax ginseng C.A. Meyer) by high-speed counter current chromatography coupled with evaporative light scattering detection. Journal of Chromatography A 2007, 1151:37-44.
15. Hale T.W., Kristensen J.H., Hackett L.P., Kohan R., Ilett K.F. Transfer of metformin into human milk. Diabetologia 2002, 45:1509-1514.
16. Hilmer S.N., Tran K., Rubie P., Wright J., Gnjidic D., Mitchell S.J., Matthews S., Carroll P.R. Gentamicin pharmacokinetics in old age and frailty. British Journal of Clinical Pharmacology 2011, 71:224-231.
17. Kanafani Z.A., Kourany W.M., Fowler V.G.J., Levine D.P., Vigliani G.A., Campion M., Katz D.E., Corey G.R., Boucher H.W. Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. European Journal of Clinical Microbiology and Infectious Diseases 2009, 28:1477-1482.
18. Kang K.S., Kim H.Y., Yamabe N., Park J.H., Yokozawa T. Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radical Research 2007, 41:1181-1188.
19. Kim G.-N., Lee J.-S., Song J.-H., Oh C.-H., Kwon Y.-I., Jang H.-D. Heat processing decreases Amadori products and increases total phenolic content and antioxidant activity of Korean Red Ginseng. Journal of Medicinal Food 2010, 13(2010):1478-1484.
20. Leblanc M., Kellum J.A., Gibney R.T., Lieberthal W., Tumlin J., Mehta R. Risk factors for acute renal failure: inherent and modifiable risks. Current Opinion in Critical Care 2005, 11:533-536.
21. Lee M.G., Chiou W.L. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. Journal of Pharmacokinetics and Biopharmaceutics 1983, 11:623-660.
22. Lee J.H., Cho S.H. Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatics model. Journal of Ethnopharmacology 2011, 133:810-817.
23. Lovas K., Fadnes D.J., Dale A. Metformin associated lactic acidosis - Case reports and literature reviews. Tidsskrift for den Norske laegeforening 2000, 120:1539-1541.
24. Mitruka B.M., Rawnsley H.M. Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals and Normal Humans 1981, Masson Publishing USA Inc., New York. second ed.
25. Morales A.I., Detaille D., Prieto M., Puente A., Briones E., Arévalo M., Leverve X., López-Novoa J.M., El-Mir M.Y. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney International 2010, 77:861-869.
26. Nasiri-Toosi Z., Dashti-Khavidaki S., Khalili H., Lessan-Pezeshki M. A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity. European Journal of Clinical Pharmacology 2012.
27. Navarro V.J., Senior J.R. Drug-related hepatotoxicity. New England Journal of Medicine 2006, 354:731-739.
28. Niyikiza C., Bajer S.D., Seitz D.E. Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy. Molecular Cancer Therapy 2002, 1:545-552.
29. Pessoa E.A., Convento M.B., Ribas O.S., Tristao V.R., Reis L.A., Borges F.T., Schor N. Preconditioning induced by gentamicin protects against acute kidney injury: the role of prostaglandins but not nitric oxide. Toxicology and Applied Pharmacology 2011, 253:1-6.
30. Petrovici C.G., Dorobat C., Bejan C., Juganariu G., Simiras E., Filip O., Luca V., Miftode E. Epidemiology and clinical features in diabetic patients with invasive infections treated at the clinical hospital of infectious diseases of Iasi, Romania, between 2008-2010. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2011, 115:1035-1041.
31. Salem E.A., Kamel M., Maarouf A.M., Bissada N.K., Hellstrom W.J., Eladl M. Amelioration of gentamicin nephrotoxicity by green tea extract in uninephrectomized rats as a model of progressive renal failure. Renal Failure 2010, 32:1210-1215.
32. Scheen A.J. Clinical pharmacokinetics of metformin. Clinical Pharmacokinetics 1996, 30:359-371.
33. Schmekal B., Pichler R., Biesenbach G. Causes and prognosis of nontraumatic acute renal failure requiring dialysis in adult patients with and without diabetes. Renal Failure 2004, 26:39-43.
34. Stojiljkovic N., Veljkovic S. Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats. Renal Failure 2009, 31:54-61.
35. Tucker G.T., Casey C., Phillips P.J., Connor H., Ward J.D., Woods H.F. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. British Journal of Clinical Pharmacology 1981, 12:235-246.
36. Wilkinson G.R., Shand D.G. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 1975, 18:377-390.
37. Xie X., Liu H., Yang M., Zuo C., Deng Y., Fan J. Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction. Chinese Journal of Integrative Medicine 2009, 15:133-140.
38. Xie X.S., Yang M., Liu H.C., Zuo C., Li H.J., Fan J.M. Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro. Journal of Ethnopharmacology 2008, 122:35-41.
39. Yokozawa T., Liu Z.W. The role of ginsenoside-Rd in cisplatin-induced acute renal failure. Renal Failure 2000, 22:115-127.
40. Yu, M., Jang, Y.H., Kang, D.H., 2013. Korean red ginseng protects the kidney from gentamicin-induced failure by modulation of oxidative stress. Journal of Ginseng Research.